A New Revenue Stream Inside Every Mammography Appointment
Cortex is a software upgrade to existing mammography hardware that adds wrist bone density assessment, completed during the scan and billed directly to the patient.
This short pre-read walks you through how it works, what patients have told us, and the economics — before a brief set of questions about the commercial model.
Before we begin
How your responses will be used
Your feedback will be used by the Cortex team to refine the commercial model and bring bone health assessment into routine mammography workflows. Responses are reviewed in aggregate. We will not share your individual responses with third parties for marketing, and you may stop at any time. Please choose the level of consent you are comfortable with below.
Your consent *
Your information will be processed in accordance with the IBEX Innovations Privacy Notice.
Watch · 3 minutes
The Cortex Patient Story
A short explainer on what the Cortex assessment looks like from the patient's perspective.
Patient explainer video
How it fits
Implementation & Workflow
Cortex is added through software, screened during the existing visit, and billed directly to the patient — with no insurance coding or reimbursement cycle.
Software Deployed to Your Mammography Hardware
We work directly with your mammography hardware provider. No new hardware. Pay-per-use.
Wrist Assessment During the Mammography Visit
The bone density measurement is a quick exposure of the wrist with minimal impact on gantry-time.
Instant Report. Direct Patient Billing at $99.
Payment is collected at point of care — cash-pay, no insurance coding, no prior authorisation, no reimbursement cycle.
Patient Survey Results
What patients told us
I would just like to say I love this idea so very much. Many people are underinformed and don't know anything about how important bone health is.
Survey respondent aged 44 · shown $99 pricing
Cortex Consumer Survey · N=198
The economics
Revenue Projection
Adjust the inputs for your own practice to see the estimated uplift. Defaults reflect a facility performing 10,000 mammograms per year.
Section 1
Institutional Overview & Demographics
Helps us understand your clinical volume and how you make new technology purchasing decisions.
1.Approximately how many mammograms does your health system or facility perform per year?
2.How much additional net revenue would an assessment need to generate per patient to justify increasing the mammography appointment window by 2 minutes?
3.Is secondary revenue considered when making a buying decision on new technology?
By secondary revenue, we mean downstream revenue generated from follow-ups on positive results within this 40–65 female demographic, such as diagnostic DEXA scans or specialist referrals.
If yes — when does secondary revenue become a meaningful factor in your executive decision-making?
4.Is providing patients with access to the latest technology part of your institution's patient value proposition?
Section 2
Clinical Proposition & Workflow Integration
How Cortex fits into your existing patient care model and operational workflow.
5.Assuming an out-of-pocket patient self-pay fee of $99 (with insurance reimbursement anticipated at a later stage), what is the maximum amount of additional technologist time that could be allocated per patient to deliver this service?
6.While consumer surveys indicate strong patient intent to opt-in, real-world adoption can vary. What do you realistically believe the actual patient adoption rate would be among eligible women aged 40–65 within your practice?
Section 3
Market Differentiation & Financial Impact
The strategic and competitive value of the service to your organisation.
7.If you were the sole provider of Cortex in your local market, do you believe this would impact choice of imaging facility among women aged 40–65?
8.Would the availability of Cortex integration influence your choice of mammography hardware system provider?
9.Would the availability of Cortex integration bring forward a planned capital hardware procurement?
Section 4
Pricing & Decision Making
10.Taking into account your facility's internal delivery, IT integration, and operational costs, what price per assessment charged to your institution by the Cortex software provider represents:
11.How likely would you be to offer Cortex to your target patient base (women 40–65) if it were available at the "fair price" you indicated in question 10?
12.What further financial, operational, or IT integration information would you require to make a final purchasing decision?
13.Do you have any additional comments you would like to make?
Thank you for completing this brief survey. Your feedback will help us bring Cortex bone health assessment into routine mammography workflows.
Thank you
Your responses have been recorded. We appreciate you taking the time to share your perspective on the Cortex commercial model — it directly shapes how we bring this to providers.